Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
- Status
- RECRUITING
- Phase
- PHASE2
Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
- Status
- TERMINATED
- Phase
- N/A
Muscle Relaxation for Pediatric Adenotonsillectomy
- Status
- COMPLETED
- Phase
- PHASE4
Parkinson's Disease Progression Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)
- Status
- TERMINATED
- Phase
- PHASE1
A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2